Detalhe da pesquisa
1.
Ensuring robustness in the quality of antibiotic susceptibility test discs for four novel antibiotics.
Biomed Chromatogr
; 36(6): e5354, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141944
2.
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3.
J Antimicrob Chemother
; 75(12): 3563-3567, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772098
3.
Identification of metabolites of novel Anti-MRSA fluoroquinolone WCK 771 in mouse, rat, rabbit, dog, monkey and human urine using liquid chromatography tandem mass spectrometry.
Biomed Chromatogr
; 33(7): e4532, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30861568
4.
Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through ß-lactam-enhancer-mechanism-based cefepime/zidebactam.
mBio
; : e0111823, 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889005
5.
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism.
Andrology
; 10(4): 669-676, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994093
6.
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals.
Diagn Microbiol Infect Dis
; 100(3): 115327, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33744624
7.
LPCN 1144 Resolves NAFLD in Hypogonadal Males.
Hepatol Commun
; 4(10): 1430-1440, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024914
8.
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.
Antimicrob Agents Chemother
; 53(2): 811-3, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19029326
9.
Development and Validation of the Chiral Liquid Chromatography Method for Separation of Enantiomeric Impurity in Novel Oxazolidinone Antibacterial Agent WCK 4086.
J Chromatogr Sci
; 56(9): 789-793, 2018 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29931104
10.
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using ß-Lactamase Inhibitors and ß-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234.
J Med Chem
; 61(9): 4067-4086, 2018 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29627985
11.
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
J Med Chem
; 48(16): 5232-42, 2005 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-16078842
12.
The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
Antimicrob Agents Chemother
; 50(11): 3568-79, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16940059
13.
Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
Antimicrob Agents Chemother
; 48(12): 4754-61, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15561853
14.
In vitro activity of the new quinolone WCK 771 against staphylococci.
Antimicrob Agents Chemother
; 48(9): 3338-42, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15328094